These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38679166)

  • 1. Current and future use of antibody-based passive immunity to prevent or control HBV/HDV infections.
    Gehring AJ; Salimzadeh L
    Antiviral Res; 2024 Jun; 226():105893. PubMed ID: 38679166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees.
    Kim SH; Shin YW; Hong KW; Chang KH; Ryoo KH; Paik SH; Kim JM; Brotman B; Pfahler W; Prince AM
    Antiviral Res; 2008 Sep; 79(3):188-91. PubMed ID: 18479762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzee.
    Iwarson S; Tabor E; Thomas HC; Goodall A; Waters J; Snoy P; Shih JW; Gerety RJ
    J Med Virol; 1985 May; 16(1):89-96. PubMed ID: 2413167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reduction of HBV and HDV infection in two indigenousmpeoples of Peruvian Amazon after the vaccination against hepatitis B].
    Cabezas C; Trujillo O; Balbuena J; Terrazas M; Manrique-de Lara C; Marín L; Ramírez-Soto MC
    Salud Publica Mex; 2020; 62(3):237-245. PubMed ID: 32520481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of blood-borne viral infections in Afghanistan.
    Husseini AA; Saeed KMI; Yurdcu E; Sertoz R; Bozdayi AM
    Arch Virol; 2019 Aug; 164(8):2083-2090. PubMed ID: 31134354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon alpha induces a stronger antiviral effect than interferon lambda in HBV/HDV infected humanized mice.
    Duehren S; Uchida T; Tsuge M; Hiraga N; Uprichard SL; Etzion O; Glenn J; Koh C; Heller T; Cotler SJ; Oka S; Chayama K; Dahari H
    Virus Res; 2024 Nov; 349():199451. PubMed ID: 39168375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B Virus-Hepatitis D Virus mother-to-child co-transmission: A retrospective study in a developed country.
    Sellier PO; Maylin S; Brichler S; Berçot B; Lopes A; Chopin D; Pogliaghi M; Munier AL; Delcey V; Simoneau G; Evans J; Gordien E; Simon F; Bergmann JF
    Liver Int; 2018 Apr; 38(4):611-618. PubMed ID: 28834623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward a Functional Cure for Hepatitis B: The Rationale and Challenges for Therapeutic Targeting of the B Cell Immune Response.
    Ma Z; Zhang E; Gao S; Xiong Y; Lu M
    Front Immunol; 2019; 10():2308. PubMed ID: 31608073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hepatitis B vaccine protects re-exposed health care workers, but does not provide sterilizing immunity.
    Werner JM; Abdalla A; Gara N; Ghany MG; Rehermann B
    Gastroenterology; 2013 Nov; 145(5):1026-34. PubMed ID: 23916846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dismantling Barriers to Hepatitis B and Delta Screening, Prevention, and Linkage to Care among the PWUD Community in Philadelphia.
    Zovich B; Freeland C; Moore H; Sapp K; Qureshi A; Holbert R; Zambrano J; Bhangoo D; Cohen C; Hass RW; Jessop A
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus entry and its inhibition to prevent and treat hepatitis B and hepatitis D virus infections.
    Tu T; Urban S
    Curr Opin Virol; 2018 Jun; 30():68-79. PubMed ID: 29775812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in the prevalence of hepatitis B and D virus infections in an endemic area in Peru 23 years after the introduction of the first pilot vaccination program against hepatitis B.
    Cabezas C; Trujillo O; Balbuena J; Peceros FM; Terrazas M; Suárez M; Marin L; Apac J; Ramírez-Soto MC
    PLoS One; 2020; 15(8):e0236993. PubMed ID: 32760100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-mediated immunotherapy against chronic hepatitis B virus infection.
    Gao Y; Zhang TY; Yuan Q; Xia NS
    Hum Vaccin Immunother; 2017 Aug; 13(8):1768-1773. PubMed ID: 28521640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo neutralization of hepatitis B virus infection by an anti-preS1 humanized antibody in chimpanzees.
    Hong HJ; Ryu CJ; Hur H; Kim S; Oh HK; Oh MS; Park SY
    Virology; 2004 Jan; 318(1):134-41. PubMed ID: 14972542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation.
    Ueda Y; Marusawa H; Egawa H; Okamoto S; Ogura Y; Oike F; Nishijima N; Takada Y; Uemoto S; Chiba T
    Antivir Ther; 2011; 16(4):479-87. PubMed ID: 21685535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognizing the impact of endemic hepatitis D virus on hepatitis B virus eradication.
    Goyal A; Murray JM
    Theor Popul Biol; 2016 Dec; 112():60-69. PubMed ID: 27594346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passively acquired antibody to hepatitis B surface antigen. Pitfall in evaluating immunity to hepatitis B viral infections.
    Devine P; Taswell HF; Moore SB; Gilchrist GS; Jacobson TM
    Arch Pathol Lab Med; 1989 May; 113(5):529-31. PubMed ID: 2712676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging anti-HDV drugs and HBV cure strategies with anti-HDV activity.
    Roca Suarez AA; Batbold E; Bartosch B; Dashdorj N; Testoni B; Zoulim F
    Liver Int; 2023 Aug; 43 Suppl 1():87-95. PubMed ID: 37017060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.
    Kim HS; Kim SJ; Park HW; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Med Virol; 2011 Jul; 83(7):1172-7. PubMed ID: 21541950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.